Communi D, Lecocq R, Vanweyenberg V, Erneux C
Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucléaire (IRIBHN), Université Libre de Bruxelles, Belgium.
Biochem J. 1995 Aug 15;310 ( Pt 1)(Pt 1):109-15. doi: 10.1042/bj3100109.
Chemical modification by phenylglyoxal, an arginine-specific reagent, of both native and recombinant rat brain inositol 1,4,5-trisphosphate [Ins(1,4,5)P3] 3-kinase A was accompanied by irreversible inhibition of enzyme activity. This effect was prevented in the presence of the substrate ATP but not Ins(1,4,5)P3. The modification reaction obeyed pseudo-first-order rate kinetics. Complete inhibition of activity corresponded to incorporation of 1.2 mol of phenylglyoxal per mol of protein. A single [14C]phenylglyoxal-modified peptide was isolated following alpha-chymotrypsin digestion of the radiolabelled Ins(1,4,5)P3 3-kinase and reverse-phase HPLC. ATP prevented the incorporation of radioactivity to this peptide. The peptide sequence (i.e. QWREGISSSTTL) corresponded to amino acids 315 to 326 of rat brain Ins(1,4,5)P3 3-kinase A. An estimate of the radioactivity of the different phenylthiohydantoin amino acid derivative showed the modified amino acid to be Arg-317. The data directly identify a reactive arginine residue as part of the ATP-binding site. Arg-317 is located within a sequence segment which is conserved among the catalytic domain of Ins(1,4,5)P3 3-kinase isoenzymes A and B in human and rat species.
用精氨酸特异性试剂苯乙二醛对天然和重组大鼠脑肌醇1,4,5 - 三磷酸[Ins(1,4,5)P3] 3 - 激酶A进行化学修饰,会伴随酶活性的不可逆抑制。在底物ATP存在时可防止这种效应,但Ins(1,4,5)P3存在时则不能。修饰反应遵循假一级反应动力学。活性的完全抑制对应于每摩尔蛋白质掺入1.2摩尔苯乙二醛。用α - 胰凝乳蛋白酶消化放射性标记的Ins(1,4,5)P3 3 - 激酶并经反相高效液相色谱法后,分离出单一的[14C]苯乙二醛修饰肽。ATP可阻止放射性掺入该肽。该肽序列(即QWREGISSSTTL)对应于大鼠脑Ins(1,4,5)P3 3 - 激酶A的第315至326位氨基酸。对不同苯硫基乙内酰脲氨基酸衍生物放射性的估计表明,被修饰的氨基酸为精氨酸 - 317。这些数据直接确定了一个反应性精氨酸残基是ATP结合位点的一部分。精氨酸 - 317位于人及大鼠物种中Ins(1,4,5)P3 3 - 激酶同工酶A和B催化结构域之间保守的序列片段内。